and to
initiate and self-regulate purposeful behavior. Apathy and abulia have been
viewed as part of a continuum of motivational impairment, with abulia representing
the more severely impaired patients 1-2 .Consistent with
this, the gross brain lesions that cause abulia may cause apathy when they are
smaller and less completely destructive, or evaluated during the recovery stage.
Akinesia
Akinesia is primarily a disorder of movement, not motivation. However, the two
syndromes are not necessarily unassociated. A mildly akinetic patient can be
severely apathetic, and a severely akinetic patient can be highly motivated.
Akinetic patients show diminution or loss of the initiation of speech and actions.
Basal ganglia disease and use of neuroleptic medications, the most prominant
causes of akinesia, also cause apathy.
Aprosodia
Aprosodia is a disorder of emotion in which patients show impaired ability to
perceive, interpret, or express emotion. Aprosodias are generally attributed
to disease of the right hemisphere. Flat affect and inappropriate cheerfulness
can occur in both apathy and aprosodia. Therefore, apathy and aprosodia may
be difficult to distinguish from each other on the basis of emotional responsivity.
Neural substrates of apathy
The neural mechanisms of apathy in neuropsychiatric disorders have been described
in a review by Mega and Cummingslo. Clinical research suggests that dopaminergic
activity mediates diminished motivation in a number of conditions, such as subcortical
diseases, frontal lobe syndromes, negative symptoms of schizophrenia, and post
psychotic depression. Thus, increasing dopaminergic activity is the primary
strategy or the pharmacologic treatment of patients with apathyB. Apathy, however,
should not be viewed simply as a problem ofdopaminergic hypoactivity 11.
Dopamine systems
Apathy has been associated with hypofunctionality of the frontal cortexlO. The
mesocortical dopaminergic system arises in the ventral tegmental area of the
mesencephalon and innervates the cerebral cortex, particularly the frontal cortex.
Increased mesocortical dopaminergic function associated with dopamine against
or stimulant therapy is presumed to be an important source of clinical improvement
in patients whose apathy is primarily associated with frontal rather than subcorticl
dysfunctonB.
The mesolimbic dopaminergic system, which also emerges from the ventral tegmental
area, innervates the nucleus accumbens, amygdala, hippocampus, ventral pallidum
and other forebrain structures. These and other interconnected structures (eg,
the medial dorsal nucleus of the thalamus, the prefrontal cortex, and the pedunculopontine
region of the brainstem) comprise a highly integrated series of circuits that
represent the motivational state of the organism. This network translates motivition
into action 12. Output of this motivation circuitry depends
substantially on the pedunculopontine region and its connection to the basal
ganglia and reticulospinal system. The benefit of dopamine aganist therapy in
cases of subcortical disorders are believed to result from an increase in mesolimbic
dopaminergic activity 8.
Frontal-Subcortical circuits
Three syndromes produced by frontal lobe damage are associated with apathy.
Each frontal region is part of a specific cortical-subcortical circuit involving
the thalamus, basal ganglia and forebrain 10,13,14. Damage
affecting the anterior cingulate/mesiofrontal region produces a clinical syndrome
of apathy. Dorsolateral prefrontal dysfunction is associates with impairment
in the executive cognition necessary for planining and monitoring goal-directed
behavior. Patients with damage to the lateral orbitoforntal cortex present with
charges in personality marked by irritability, angry outbursts, or disinhibited
sexuaj behavior. In these patients, however, there is often an underlying background
of abulia and apathy that pervades the clinical picture.15 These frontal regions
are connected to specific regions of caudate nucles, nucles accumbens, globus
pallidus, and medical dorsal nucleus of the thalamus. Injury to any component
of these three circuits produces the behavioral, emotional, and/or cognitive
symptoms of that circuit.
Clinical causes of apathy
Clinically significant apathy can be due to primary neurologic processes and
medical conditions that alter the neural systems subserving motivation. Table-2
lists clinical conditions associated with apathy.
Alzheimer disease
Apathy is a pervasive neurobehavioral disturbance in Alzheimer disease16. The
prevalence and severity of the syndrome of apathy increases with the progression
of Alzheimer disease, with prevalence reports varying from 29% to 88%.17-19
Functional imaging studies suggest that the syndrom of apathy in this patient
group is related to the severity of prefrontal and anterior temporal dysfunction
20.
Frontal lobe dysfunction
Neurologic diseases of any etiology affecting the frontal lobes produce changes
in cognition and behavior in which motivational loss is often sufficiently prominent
to be characterized as a syndrome of apathy. Multiple sclerosis, Pick's disease,
other non-Alzheimer frontal dementias, frontal tumors, stroke, and hydrocephalus
are examples of patholigic processes that may produce frontal lobe syndromes
21
Basal ganglia disease
The syndrom of apathy has been associated with damage to the ventral striatum
and globus pallidus 10,14. Systematic investigations of
basal ganglia disease have focused primarily on Parkinson's disease 7,20,22,
Huntington's disease l7,18 Progressive supranuclear palsy
23. and human immunodeficiency virus HIV) infection.24
In these and other subcortical diseases, loss of motivation often occurs in
association with symptoms of mood disturbance and cognitive loss. HIV infection
can leadto significant neuronal cell loss in the basal ganglia. Clinical studies
indicate that apathy may reach syndromal proportions in the latter stages of
disease progression 24. A recent study examined the relationship
between apathy, depression and neurocognitive functioning during the asymptomatic
stage of HIV infection 25. The study results showed that
psychomotor slowing was associated with an increase in apathy but not depression
in this cohort. These findings support the notion that apathy.symptoms may be
one of the earliest clinical manifestations of central of nervous system involvement
in HIV-infected patients.
Diencephalic and amygdala damage
Dysfunction of the diencephalon and amygdala may also produce the syndrome of
apathy. The best known of the conditions affecting these areas of the brain
is Korsakoff's syndrome. Tumor, stroke, and trauma injuring the diencephalon
may also produce a syndrome of apathy. The
  |